Crispr Therapeutics AG (CRSPN) Q2 2018 Earnings Report
1 Followers
MX:CRSPN Q2 2018 EPS Results
- Actual EPS
- -MXN 15.45
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 10.55
MX:CRSPN Q2 2018 Revenue Results
- Actual Revenue
- MXN 20.50M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/07/2018
- Time
- TBA
- Conference Call
- Tuesday, August 7, 2018
MX:CRSPN Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:CRSPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | -22.12- | -25.81 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -19.53-21.66 | -22.04 | 1.71% (+0.38) | |
| Aug 03, 2026 | 2026 (Q2) | -22.51-17.71 | -45.21 | 60.83% (+27.50) | |
| May 04, 2026 | 2026 (Q1) | -22.94-24.11 | -29.76 | 18.99% (+5.65) | |
| Feb 12, 2026 | 2025 (Q4) | -21.91-25.81 | -8.29 | -211.36% (-17.52) | |
| Nov 10, 2025 | 2025 (Q3) | -23.83-22.04 | -19.03 | -15.84% (-3.01) | |
| Aug 04, 2025 | 2025 (Q2) | -26.41-45.21 | -28.07 | -61.07% (-17.14) | |
| May 06, 2025 | 2025 (Q1) | -23.43-29.76 | -26.94 | -10.49% (-2.83) | |
| Feb 11, 2025 | 2024 (Q4) | -22.62-8.29 | 20.72 | -140.00% (-29.01) | |
| Nov 05, 2024 | 2024 (Q3) | -26.52-19.03 | -26.56 | 28.37% (+7.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
